Abstract
It is convenient to classify the manifestations of liver disease related to alcoholism into three types: (1) alcoholic fatty liver, (2) alcoholic hepatitis, and (3) cirrhosis. Light microscopic morphologic findings in these three categories, however, may coexist or overlap.1–5 In addition, there is frequently a poor correlation between the clinical, biochemical, and morphological findings in patients with alcohol-related liver injury. Further difficulties in morphologic interpretation arise from the recognition of a variety of clinical settings or entities unrelated to alcohol ingestion that may mimic alcoholic liver disease, and from alterations superimposed on alcohol-related liver injury by causes, such as viral hepatitis, drug-induced hepatotoxicity, and biliary tract obstruction.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Baptista A, Bianchi L, DeGroote J, et al: Alcoholic liver disease: Morphologic manifestations. Lancet 1:707–711, 1982.
French SW, Burbege EJ: Alcoholic hepatitis; clinical, morphologic, pathogenic and therapeutic aspects. Prog Liver Dis 6:557–579, 1979.
Hall P: The pathological spectrum of alcoholic liver disease. Pathology 17:209–218, 1985.
MacSween RNM, Burt AD: Histologic spectrum of alcoholic liver disease. Semin Liver Dis 6:221–232, 1986.
Desmet VJ: Alcoholic liver disease. Histological features and evolution. Acta Med Scand 703(suppl): 111–126, 1985.
Lieber CS, Jones DP, DeCarli LM: Effects of prolonged ethanol intake: Production of fatty liver despite adequate diets. J Clin Invest 44:1009–1021, 1965.
Rubin E, Lieber CS: Alcohol-induced hepatic injury in nonalcoholic volunteers. Engl J Med 278:869–876, 1968.
Lieber CS: Metabolism and metabolic effects of ethanol. Med Clin North Am 68:3–31, 1984.
Christofferson P, Poulsen H: Alcoholic liver disease, in MacSween RNM, Anthony PP, Scheuer PF (eds): Pathology of the Liver. Churchill-Livingstone, Edinburgh, 1979, pp. 232–248.
Randall B: Sudden death and hepatic fatty metamorphosis. JAMA 243:1723–1725, 1980.
Randall B: Fatty liver and sudden death. Hum Pathol 11:147–153, 1980.
Popper H, Szanto RB: Fatty liver with hepatic failure in alcoholics. J Mt Sinai Hosp 24:1121–1131, 1957.
Uchida T, Kao H, Quispe-Sjogren M, et al: Alcoholic foamy degeneration—A pattern of acute alcoholic injury of the liver. Gastroenterology 84:683–692, 1983.
Kunelis CT, Peters RL, Edmondson HA: Fatty liver of pregnancy and its relationship to tetracycline. Am. J Med 38:359–377, 1965.
Rolfes, DB, Ishak KG: Acute fatty liver of pregnancy. A clinicopathologic study of 35 cases. Hepatology 5:1149–1158, 1985.
Bove KE, McAdams AJ, Partin JC, et al: The hepatic lesion in Reye’s syndrome. Gastroenterology 69:685–697, 1975.
Davis J: Liver damage due to tetracycline and its relationship to pregnancy, in Meyler L, Peck HM (eds): Drug-Induced Diseases. Excerpta Medica Foundation, Amsterdam, 1968, pp. 103–110.
Peters RL, Edmondson HA, Mikkelsen WP, et al: Tetracycline-induced fatty liver in non-pregnant patients. Am J Surg 113:622–632, 1967.
Zimmerman HJ, Ishak KG: Valproate induced hepatic injury. Analysis of 23 fatal cases. Hepatology 2:591–597, 1982.
Starko KM, Mullick FG: Hepatic and cerebral pathology findings in children with fatal salicylate intoxication. Lancet 1:326–329, 1983.
Wolman M, Sterk VV, Gatt S, et al: Primary familial xanthomatosis with involvement and calcification of adrenals. Pediatrics 28:742–745, 1961.
Miller R, Bialer MG, Rogers F, et al: Wolman’s disease. Report of a case with multiple studies. Arch Pathol Lab Med 106:41–45, 1982.
Schiff L, Schubert WK, McAdams A, et al: Hepatic cholesterol ester storage disease, a familial disorder. Am J Med 44:538–546, 1968.
Walser M: Urea cycle disorders and other hyperammonemic syndromes, in Stanbury JB, Wyngaarden JB, Fredrickson DS, et al. (eds): The Metabolic Basis of Inherited Disease, 5th ed. McGraw-Hill, New York, 1983, pp. 402–438.
Glasgow AM, Eng G, Engel AG: Systemic carnitine deficiency simulating Reye’s syndrome. J Pediatr 96:889–891, 1980.
French SW: Present understanding of the development of Mallory bodies. Arch Pathol Lab Med 88:445–450, 1982.
Denk H, Lockinger E, Vennigerholtz F: Pathology of the cytoskeleton of hepatocytes, in Popper H, Schaffner F (eds): Progress in Liver Diseases, Vol. VIII. Grime & Stratton, Orlando, Florida, 1986, pp. 237–251.
Goodman ZD, Ishak KG: Occlusive venous lesions in alcoholic liver disease. A study of 200 cases. Gastroenterology 83:786–796, 1982.
Van de Wiel A, Delacroix DL, Van Hattum J, et al: Characteristics of serum 1gA and liver 1gA deposits in alcoholic liver disease. Hepatology 7:95–99, 1987.
Uchida T, Kronborg I, Peters RL: Giant mitochondria in alcoholic liver disease—Their identification, frequency and pathologic significance. Liver 4:29–38, 1984.
Chedid A, Mendenhall S, Tosch T, et al: Significance of megamitochondria in alcoholic liver disease. Gastroenterology 90:1858–1864, 1986.
Afroudakis A, Kaplowitz N: Liver histopathology in chronic common bile duct stenosis due to chronic alcoholic pancreatitis. Hepatology 1:65–72, 1981.
Schenker S. Alcoholic liver disease: Evaluation of natural history and prognostic factors. Hepatology 4:36S–43S, 1984.
Orrego H, Blake JE, Blendis LM, et al: Prognosis of alcoholic cirrhosis in the presence and absence of alcoholic hepatitis. Gastroenterology 92:208–214, 1987.
Anthony PP, Ishak KG, Nayak NC, et al: The morphology of cirrhosis. Bull WHO 4:521–540, 1977.
Pariente EA, Degott C, Martin JP, et al: Hepatocytic PAS-positive diastase resitant inclusions in the absence of alpha-1-antitrypsin deficiency—High prevalence in alcoholic cirrhosis. Am J Clin Pathol 76:299–302, 1981.
Goldberg SJ, Mendenhall CL, Cannell AM, et al: “Nonalcoholic”chronic hepatitis in the alcoholic. Gastroenterology 72:598–604, 1977.
Crapper RM, Bhatal PS, MacKay JR: Chronic active hepatitis in alcoholic patients. Liver 3:327–337, 1983.
Nei J, Matsuda Y, Takada A: Chronic hepatitis induced by alcohol. Dig Dis Sci 28:207–215, 1983.
Adler M, Schaffner F: Fatty liver hepatitis and cirrhosis in obese patients. Am J Med 67:811–816, 1979.
Ludwig J, Viggiano TR, McGill DB, et al: Non-alcoholic steatohepatitis. Mayo Clin Proc 55:434–438, 1980.
Schaffner F, Thaler H: Non-alcoholic fatty liver disease, in Popper H, Schaffner F (eds): Progress in Liver Disease, Vol. VIII. Grune & Stratton, Orlando, Florida, 1986, pp. 283–298.
Peters RL, Gary T, Reynolds TB: Post-jejunoileal bypass hepatic disease. Its similarity to alcoholic hepatic disease. Am J Clin Pathol 63:318–331, 1975.
Craig RM, Newman T, Jeejeebhoy KN, et al: Severe hepatocellular reaction resembling alcoholic hepatitis with cirrhosis after massive small bowel resection and prolonged total parenteral nutrition. Gastroenterology 79:131–137, 1980.
Bloomer JR: The hepatic porphyrias. Gastroenterology 71:689–701, 1976.
Fakan F, Chlumska A: Demonstration of needle-shaped hepatic inclusions in porphyria cutanea tarda using the ferric ferricyanide reduction test. Virchows Arch A 411:365–368, 1987.
Roy S, Ramalingaswami V, Nayak NC: An ultrastructural study of the liver in Indian childhood cirrhosis with particular reference to the structure of cytoplasmic hyaline. Gut 12:693–701, 1971.
Sternlieb I: Evolution of the hepatic lesion in Wilson’s disease (hepatolenticular degeneration), in Popper H, Schaffner F (eds): Progress in Liver Diseases, Vol. IV. Grune & Stratton, Orlando, Florida, 1979, pp. 511–525.
Denk H, Eckerstorfer R, Gschnait F, et al: Experimental induction of hepatocellular hyaline (Mallory bodies) in mice by griseofulvin treatment. I. Light microscopic observations. Lab Invest 35:377–382, 1976.
Denk H, Eckerstorfer R: Colchicine-induced Mallory body formation in the mouse. Lab Invest 30:563–565, 1977.
Meierhenry EF, Reubner BH, Gershwin ME, et al: Mallory body formation in hepatic nodules of mice ingesting dieldrin. Lab Invest 44:392–396, 1981.
Lewis JH, Ranard RC, Caruso A, et al: Amiodarone hepatotoxicity: Incidence and clinical pathologic correlations among 104 patients. Hepatology in press, 1989.
Simon JB, Manley RN, Brien JF, et al: Amiodarone hepatotoxicity simulating alcoholic liver disease. S Engl J Med 311:167–172, 1984.
Pessayre D, Bichara M, Feldmann G, et al: Perhexiline maleate-induced cirrhosis. Gastroenterology 76:170–177, 1979.
Rosensztajn L, deSaint-Maus PP: Perhexiline maleate-associated hepatic injury. Prevalence and characteristics. Digestion 20:145–150, 1980.
Seki K, Minami Y, Nishikawa M, et al: “Non-alcoholic steatohepatitis” induced by massive doses of synthetic estrogen. Gastroenterol Jpn 18:197–203, 1983.
Itoh S, Igrashi M, Tsukada Y, et al: Non-alcoholic fatty liver with alcoholic hyaline after long term glucocorticoid therapy. Acta Hepatogastroenterol 24:415–418, 1977.
Monroe S, French SW, Zamboni L: Mallory bodies in a case of biliary cirrhosis: An ultrastructural and morphogenetic study. Am J Clin Pathol 59:254–262, 1973.
Jones EA, Rabin L, Buckley CH, et al: Progressive intrahepatic cholestasis of infancy and childhood. A clinicopathological study of a patient surviving to the age of 18 years. Gastroenterology 71:675–682, 1976.
French SW: Present understanding of the development of Mallory bodies. Arch Pathol Lab Med 107:445–450, 1983.
French SW: The Mallory body: Structure, composition and pathogenesis. Hepatology 1:76–83, 1981.
Yokoo H, Minick OT, Batti F, et al: Morphologic variants of alcoholic hyalin. Am J Pathol 69:25–40, 1972.
Seeff LB, Cuccherini SA, Zimmerman HJ, et al: Acetaminophen hepatotoxicity in alcoholics. A therapeutic misadventure. Ann Intern Med 104:399–404, 1986.
Lieber C, Garro A, Leo MA, et al: Alcohol and cancer. Hepatology 6:1005–1019, 1986.
Kimura H, Kako M, Yo K, et al: Alcoholic hyaline (Mallory bodies) in a case of Weber-Christian disease. Gastroenterology 78:807–812, 1980.
Partin JS, Partin JC, Schubert WK, et al: Liver ultrastructure in abetalipoproteinemia: Evolution of micro-nodular cirrhosis. Gastroenterology 67:107–118, 1974.
Keeley AF, Iseri OA, Gottlieb LS: Ultrastructure of hyaline cytoplasmic inclusions in human hepatoma: Relationship to Mallory’s alcoholic hyaline. Gastroenterology 62:280–293, 1972.
Wetzel WJ, Alexander RW: Focal nodular hyperplasia of the liver with alcoholic hyaline bodies and cytologic atypia. Cancer 44:1322–1326, 1979.
Warnock ML, Press M, Churg A: Further observations on cytoplasmic hyaline in the lung. Hum Pathol 11:59–65, 1980.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Publishing Corporation
About this chapter
Cite this chapter
Rabin, L. (1989). The Morphological Spectrum of Alcoholic Liver Disease. In: Seeff, L.B., Lewis, J.H. (eds) Current Perspectives in Hepatology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-7041-3_11
Download citation
DOI: https://doi.org/10.1007/978-1-4684-7041-3_11
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-7043-7
Online ISBN: 978-1-4684-7041-3
eBook Packages: Springer Book Archive